HOLON, Israel (AP) — HOLON, Israel (AP) — Compugen Ltd. (CGEN) on Wednesday reported a loss of $7.3 million in its second quarter.
On a per-share basis, the Holon, Israel-based company said it had a loss of 8 cents.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 7 cents per share.
The drug developer posted revenue of $1.3 million in the period, which also did not meet Street forecasts. Three analysts surveyed by Zacks expected $5.3 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CGEN at https://www.zacks.com/ap/CGEN
Copyright © 2026 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
